共 12 条
- [1] Tan A, Stewart CJ, Garrett KL, Rye M, Cohen PA., Novel BRAF and KRAS mutations in papillary thyroid carcinoma arising in struma ovarii, Endocrine Pathology, 26, pp. 296-301, (2015)
- [2] Grandet PJ, Remi MH., Struma ovarii with hyperthyroidism, Clinical Nuclear Medicine, 25, pp. 763-765, (2000)
- [3] Yoo SC, Chang KH, Lyu MO, Chang SJ, Ryu HS, Kim HS., Clinical characteristics of struma ovarii, Journal of Gynecologic Oncology, 19, pp. 135-138, (2008)
- [4] Plaut A., Ovarian struma: a morphologic, pharmacologic, and biologic examination, American Journal of Obstetrics and Gynecology, 25, pp. 351-359, (1933)
- [5] Mimura Y, Kishida M, Masuyama H, Suwaki N, Kodama J, Otsuka F, Kataoka H, Yamauchi T, Ogura T, Kudo T, Et al., Coexistence of Graves’ disease and struma ovarii: case report and literature review, Endocrine Journal, 48, pp. 255-260, (2001)
- [6] Zhang R, Tian X, Luo Y, Dong H, Tian W, Zhang Y, Li D, Sun H, Meng Z., Case report: recurrent malignant struma ovarii with hyperthyroidism and metastases, a rare case report and review of the literature, Pathology Oncology Research, 28, (2022)
- [7] Robboy SJ, Shaco-Levy R, Peng RY, Snyder MJ, Donahue J, Bentley RC, Bean S, Krigman HR, Roth LM, Young RH., Malignant struma ovarii: an analysis of 88 cases, including 27 with extraovarian spread, International Journal of Gynecological Pathology, 28, pp. 405-422, (2009)
- [8] Marcus CC, Marcus SL., Struma ovarii. A report of 7 cases and a review of the subject, American Journal of Obstetrics and Gynecology, 81, pp. 752-762, (1961)
- [9] Yoshioka W, Miyauchi A, Ito M, Kudo T, Tamai H, Nishihara E, Kihara M, Miya A, Amino N., Kinetic analyses of changes in serum TSH receptor antibody values after total thyroidectomy in patients with Graves’ disease, Endocrine Journal, 63, pp. 179-185, (2016)
- [10] Yassa L, Sadow P, Marqusee E., Malignant struma ovarii. Nature Clinical Practice, Endocrinology and Metabolism, 4, pp. 469-472, (2008)